Outperform Recommendation Issued On RYTM By RBC Capital
Source: KlickAnalytics
2026-02-18 16:15:03 ET
Historical Analyst Recommendations
Latest 10 recommendations| Report Date< ... Full story available on KlickAnalytics.com |
Rhythm Pharmaceuticals Inc.
NASDAQ: RYTM
RYTM Trading
-0.51% G/L:
$91.335 Last:
200,656 Volume:
$94.27 Open:
RYTM Latest News
March 01, 2026 12:30:00 pm
Rhythm Pharmaceuticals Announces Additional Positive Data from Phase 3 TRANSCEND trial of Setmelanotide in Patients with Acquired Hypothalamic Obesity
February 26, 2026 07:00:00 am
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update
RYTM Stock Data
$6,891,165,143
62,665,157
0.73%
95
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
